GlassScriptAvid Ct2 Nmes/Ifc Stimulator
Payments companies reported to CMS as associated with Avid Ct2 Nmes/Ifc Stimulator. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Avid Ct2 Nmes/Ifc Stimulator, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Avid Ct2 Nmes/Ifc Stimulator
These are the largest totals companies reported as associated with Avid Ct2 Nmes/Ifc Stimulator. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Steve Mora | Orange, CA | Orthopaedic Surgery | $154.48 |
| Michael Moon | San Diego, CA | Interventional Pain Medicine | $126.85 |
| Ara Dikranian | San Diego, CA | Rheumatology | $87.87 |
| Kelly Jones | Montgomery, AL | Family | $72.56 |
| Jacob Vella | Montgomery, AL | Interventional Pain Medicine | $72.56 |
| Murad Arif | Murrieta, CA | Anesthesiology | $67.80 |
| Blake Thompson | San Diego, CA | Physical Medicine & Rehabilitation | $53.60 |
| Marc Lynch | Chino, CA | Interventional Pain Medicine | $52.41 |
| Parveen Ahmed | Pico Rivera, CA | Internal Medicine | $38.87 |
| Payam Moazzaz | Oceanside, CA | Orthopaedic Surgery of The Spine | $29.87 |
Prescribed Avid Ct2 Nmes/Ifc Stimulator?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.